- Research Grants
bachelor's at Ciências Biológicas - Bacharelado from Universidade de São Paulo (2006), bachelor's at Ciências Biológicas - Licenciatura from Universidade de São Paulo (2007), master's at Pharmacy from Universidade de São Paulo (2009) and doctorate at Pharmacy from Universidade de São Paulo (2014). , acting on the following subjects: mmp, glioma, reck, melanoma, and 2-metoxiestradiol. (Source: Lattes Curriculum)
Melanomas are the deadliest form of skin cancer and, despite the low incidence, they represent 80% of the deaths from this type of tumor. The development of specific inhibitors to the mutant form of the onco-protein BRAF has put melanoma among the tumors benefiting from this compound, following the tendency of treatments that exploit the principle of molecular targeted therapy. However,...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|